Immuron Plans Phase 2 Trial for IMM-529 following FDA review
Released
Latest announcements
Announcement summary
Immuron Plans Phase 2 Trial for IMM-529 following FDA review
Ask a question
Your question will be visible to everyone.
Investor Q&As
Start the conversation
Ask Immuron a question about this announcement.